Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA warns surgeries over inappropriate advertising of Allergan's Lap-Band

This article was originally published in Clinica

Executive Summary

The US FDA has sent warning letters to several US institutions over misleading advertising of Allergan's gastric band Lap-Band. The letters, which went to eight surgical centres in California and the marketing firm 1-800-GET-THIN, said that their adverts for Lap-Band failed to provide required information on the risks and possible side-effects of the product. The FDA is also concerned that the font size of risk information on the advertising inserts is "too small to be read by customers".

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT098302

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel